Autoimmune Diseases

• 

  Subject Areas on Research

  • 60-kDa Ro protein autoepitopes identified using recombinant polypeptides. 
  • A gene expression signature for recent onset rheumatoid arthritis in peripheral blood mononuclear cells. 
  • A genomewide screen in multiplex rheumatoid arthritis families suggests genetic overlap with other autoimmune diseases. 
  • A human autoimmune protein associated with U1 RNA contains a region of homology that is cross-reactive with retroviral p30gag antigen. 
  • A molecular basis for MHC class II--associated autoimmunity. 
  • A murine model of congenital toxoplasmic retinochoroiditis. 
  • A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. 
  • A role for plasma cell targeting agents in immune tolerance induction in autoimmune disease and antibody responses to therapeutic proteins. 
  • A subset of Rosai-Dorfman disease exhibits features of IgG4-related disease. 
  • Adrenoleukodystrophy associated with vitiligo and ulcerative colitis. 
  • Advancing research in autoimmune neuromuscular disorders. 
  • Age-dependent alterations of peritoneal exudate macrophages in autoimmune-prone and autoimmune-resistant mouse strains. 
  • Alemtuzumab vs. interferon beta-1a in early multiple sclerosis. 
  • Allogeneic HSCT for autoimmune disease: a shared decision. 
  • Altered T-dependent antigen responses and development of autoimmune symptoms in mice lacking E2A in T lymphocytes. 
  • Alternative splicing in multiple sclerosis and other autoimmune diseases. 
  • Amicrobial Pustulosis of the Folds and Autoimmunity. 
  • Angiotensin II plays a role in acute murine experimental autoimmune cystitis. 
  • Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. 
  • Anti-DNA antibodies from autoimmune mice arise by clonal expansion and somatic mutation. 
  • Anti-Interleukin-6 Antibodies for Autoimmune Retinopathy with Macular Edema. 
  • Anti-cell surface pemphigus autoantibody stimulates plasminogen activator activity of human epidermal cells. A mechanism for the loss of epidermal cohesion and blister formation. 
  • Anti-idiotypic antibodies as vaccine candidates. The immune network. 
  • Anti-self HLA may be clonally expressed. 
  • Antibodies to granulocyte precursors in selective myeloid hypoplasia and other suspected autoimmune neutropenias: use of HL-60 cells as targets. 
  • Antibody isotype-specific engagement of Fcgamma receptors regulates B lymphocyte depletion during CD20 immunotherapy. 
  • Antibody responses to DNA in normal immunity and aberrant immunity. 
  • Antigen-binding repertoire and Ig H chain gene usage among B cell hybridomas from normal and autoimmune mice. 
  • Antihuman factor V antibodies after use of relatively pure bovine thrombin. 
  • Apolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury. 
  • Application of stem cell transplantation in autoimmune diseases. 
  • Association between cell-mediated demyelination and astrocyte stimulation. 
  • Association of Wegener's granulomatosis with HLA-B8. 
  • Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. 
  • Atomic description of the immune complex involved in heparin-induced thrombocytopenia. 
  • Autoantibodies specific for U1 RNA and initiator methionine tRNA. 
  • Autoantibodies to Dense Fine Speckles in Pediatric Diseases and Controls. 
  • Autoimmune dacryoadenitis of NOD/LtJ mice and its subsequent effects on tear protein composition. 
  • Autoimmune disease incidence among women prenatally exposed to diethylstilbestrol. 
  • Autoimmune encephalitis: proposed best practice recommendations for diagnosis and acute management. 
  • Autoimmune meningoencephalitis in a melanoma patient treated with ipilimumab. 
  • Autoimmune pancerebellitis associated with pembrolizumab therapy. 
  • Autoimmune retinopathy and antiretinal antibodies: a review. 
  • Autoimmunity in dry eye is due to resistance of Th17 to Treg suppression. 
  • Autoimmunity to the alpha 3 chain of type IV collagen in glomerulonephritis is triggered by 'autoantigen complementarity'. 
  • Autoimmunity: regulatory B cells--IL-35 and IL-21 regulate the regulators. 
  • Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European League Against Rheumatism and the International Stem Cell Project for Autoimmune Disease. 
  • Autologous stem cell transplantation for autoimmune diseases: issues in protocol development. 
  • B cell-ablative therapy for the treatment of autoimmune diseases. 
  • B cell-directed therapies for autoimmune disease and correlates of disease response and relapse. 
  • B cells as a therapeutic target in autoimmune diseases. 
  • B lymphocytes contribute to autoimmune disease pathogenesis: current trends and clinical implications. 
  • B lymphocytes: how they develop and function. 
  • B-lymphocyte contributions to human autoimmune disease. 
  • B-lymphocyte effector functions in health and disease. 
  • B10 cell regulation of health and disease. 
  • Bone marrow transplantation for non-malignant disease. 
  • Bovine thrombin and systemic autoimmunity. 
  • CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. 
  • CD22 and Siglec-G in B cell function and tolerance. 
  • Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. 
  • Cellular targeting in autoimmunity. 
  • Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies. 
  • Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. 
  • Characterization of monoclonal antibodies with specificity for DNA and the synthetic polypeptide antigen (T,G)-A-L. 
  • Chimerism in myositis. 
  • Choroidal Thickness and En Face Optical Coherence Tomography Imaging in Autoimmune Retinopathy. 
  • Circulating galectin-3 in infections and non-infectious inflammatory diseases. 
  • Classical Hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. 
  • Clinical and electroencephalographic correlates in Rasmussen's encephalitis. 
  • Clinical and immunologic features of selective IgA deficiency. 
  • Clinical and serologic manifestations of autoimmune disease in MRL-lpr/lpr mice lacking nitric oxide synthase type 2. 
  • Cloned endothelium derived from autoimmune vascular disease retain structural and functional characteristics of normal endothelial cells. 
  • Cloning of B cells from autoimmune MRL-lpr/lpr and MRL.xid mice. 
  • Comparison of the efficacy of a two-day and a five-day schedule for infusing intravenous gamma globulin in the treatment of immune thrombocytopenic purpura in adults. 
  • Cryptococcus deuterogattii VGIIa Infection Associated with Travel to the Pacific Northwest Outbreak Region in an Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibody-Positive Patient in the United States. 
  • Cutaneous manifestations as presenting sign of autoimmune lymphoproliferative syndrome in childhood. 
  • Cutaneous polyarteritis nodosa localized to a region of lymphedema secondary to Streptococcus viridans cellulitis and multiple surgeries. 
  • Cyclophosphamide therapy of peripheral uveitis. 
  • Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss. 
  • Defects in mononuclear phagocytic system (MPS) function in autoimmune MRL-lpr/lpr mice. 
  • Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia. 
  • Dermatologic aspects of thyroid disease. 
  • Development of a protocol for allogeneic marrow transplantation for severe systemic sclerosis: paradigm for autoimmune disease. 
  • Development of bullous pemphigoid after allogeneic bone marrow transplantation. Report of a case. 
  • Diagnosis of phacoanaphylactic endophthalmitis by fine needle aspiration biopsy. 
  • Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy. 
  • Dietary Methionine in T Cell Biology and Autoimmune Disease. 
  • Digoxin and its derivatives suppress TH17 cell differentiation by antagonizing RORγt activity. 
  • E proteins in lymphocyte development and lymphoid diseases. 
  • Eating Disorders, Autoimmune, and Autoinflammatory Disease. 
  • Editorial: Stem cell transplantation in autoimmune diseases (AID). 
  • Editorial: The Role of Nuclear Molecules in the Pathogenesis of Autoimmune Disease. 
  • Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors. 
  • Effects of acute and chronic inflammation on B-cell development and differentiation. 
  • Effects of sequence variation on differential allelic transcription factor occupancy and gene expression. 
  • Effects of the lpr mutation on elimination and inactivation of self-reactive B cells. 
  • Efficacy of intravenous gamma globulin in autoimmune-mediated pediatric blood dyscrasias. 
  • Emerging immunotherapies for autoimmune kidney disease. 
  • Emerging insights into the genesis of epilepsy. 
  • Endogenous IL-12 is required for induction and expression of experimental autoimmune uveitis. 
  • Enhanced Th17-cell responses render CCR2-deficient mice more susceptible for autoimmune arthritis. 
  • Epitope specificity of anti-La antibodies from patients with Sjögren's syndrome. 
  • Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases. 
  • Escape from tolerance in the human X-linked autoimmunity-allergic disregulation syndrome and the Scurfy mouse. 
  • Evaluation of microarray surfaces and arraying parameters for autoantibody profiling. 
  • Evolving story of autoantibodies in systemic lupus erythematosus. 
  • Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor. 
  • Experimental autoimmune myasthenia gravis in rats. Modification by thymectomy and prednisolone. 
  • Experimental autoimmune myasthenia gravis: effects of calcium and potassium on the spontaneous release of neuromuscular transmitter. 
  • Experimental autoimmune uveoretinitis and pinealitis induced by interphotoreceptor retinoid-binding protein and S-antigen: induction of intraretinal and subretinal neovascularization. 
  • Exposure of mice to topical bovine thrombin induces systemic autoimmunity. 
  • Expression of a highly conserved anti-DNA idiotype in normal and autoimmune mice. 
  • Extracorporeal photochemotherapy for drug-resistant pemphigus vulgaris. 
  • FOXP3 expression following bone marrow transplantation for IPEX syndrome after reduced-intensity conditioning. 
  • Factors associated with reduced infliximab exposure in the treatment of pediatric autoimmune disorders: a cross-sectional prospective convenience sampling study. 
  • Fas on renal parenchymal cells does not promote autoimmune nephritis in MRL mice. 
  • Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations. 
  • Fatal recurrence of autoimmune hemolytic anemia following pentostatin therapy in a patient with a history of fludarabine-associated hemolytic anemia. 
  • Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005. 
  • Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. 
  • Fulfilling Koch's postulates of autoimmunity: anti-NR2 antibodies in mice and men. 
  • G-protein signaling modulator-3, a gene linked to autoimmune diseases, regulates monocyte function and its deficiency protects from inflammatory arthritis. 
  • GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum. 
  • Gait abnormalities and inflammatory cytokines in an autologous nucleus pulposus model of radiculopathy. 
  • Gastric lesions in patients with autoimmune metaplastic atrophic gastritis (AMAG) in a tertiary care setting. 
  • Gene expression profiling in human autoimmunity. 
  • Genetic analysis of MRL-lpr mice: relationship of the Fas apoptosis gene to disease manifestations and renal disease-modifying loci. 
  • Genetic sharing and heritability of paediatric age of onset autoimmune diseases. 
  • Genome-wide Pleiotropy Between Parkinson Disease and Autoimmune Diseases. 
  • Genome-wide association study in 79,366 European-ancestry individuals informs the genetic architecture of 25-hydroxyvitamin D levels. 
  • Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. 
  • Genome-wide regulatory analysis using en masse nuclear run-ons and ribonomic profiling with autoimmune sera. 
  • Germinal center B cell depletion diminishes CD4+ follicular T helper cells in autoimmune mice. 
  • Glomerular type 1 angiotensin receptors augment kidney injury and inflammation in murine autoimmune nephritis. 
  • Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival. 
  • Glutamate receptor GluR3 antibodies and death of cortical cells. 
  • Graft-v-host disease is associated with autoimmune-like thrombocytopenia. 
  • Graft-versus-host disease: allo- and autoimmunity after bone marrow transplantation. 
  • Guidelines for assessing immunocompetency in clinical trials for autoimmune diseases. 
  • HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease. 
  • Hematopoietic cell transplantation for autoimmune disease: updates from Europe and the United States. 
  • Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly. 
  • Hepatic manifestations of systemic disease: an imaging-based review. 
  • Holding the Inflammatory System in Check: TLRs and NLRs. 
  • ICAM-1 expression in autoimmune encephalitis visualized using magnetic resonance imaging. 
  • IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response. 
  • IL-10-producing regulatory B cells (B10 cells) in autoimmune disease. 
  • IRGM1 links mitochondrial quality control to autoimmunity. 
  • Idiotypes, anti-idiotypes, and autoimmunity. 
  • IgG antibodies from patients with bullous pemphigoid bind to localized epitopes on synthetic peptides encoded by bullous pemphigoid antigen cDNA. 
  • IgG antinuclear antibodies with cross-reactive rheumatoid factor activity. 
  • IgG4-Related Disease of Bilateral Temporal Bones. 
  • Immune Tolerance for Autoimmune Disease and Cell Transplantation. 
  • Immune recognition of DNA in SLE. 
  • Immune reconstitution syndrome and exacerbation of infections after pregnancy. 
  • Immunization with the Sm nuclear antigen induces anti-Sm antibodies in normal and MRL mice. 
  • Immunological properties of bacterial DNA. 
  • Immunology of pregnancy and reproductive health in autoimmune rheumatic diseases. Update from the 11th International Conference on Reproduction, Pregnancy and Rheumatic Diseases. 
  • Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. 
  • Immunophenotyping of chimeric cells in localized scleroderma. 
  • Immunoregulation of CNS autoimmunity by helminth and mycobacterial infections. 
  • Immunosuppressive/Autoimmune Disorders. 
  • Immunotherapy in selected patients with Down syndrome disintegrative disorder. 
  • Immunotherapy using unconjugated CD19 monoclonal antibodies in animal models for B lymphocyte malignancies and autoimmune disease. 
  • In vitro studies of acantholysis of keratinocytes induced by pemphigus antibody. 
  • Incidence of autoimmune disease in patients after breast reconstruction with silicone gel implants versus autogenous tissue: a preliminary report. 
  • Increased serum levels of macrophage colony-stimulating factor in ovarian cancer. 
  • Infection and cyclosporine. 
  • Inflammation and Immune Response in Arrhythmogenic Cardiomyopathy: State-of-the-Art Review. 
  • Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II. 
  • Inhibition of in vitro NZB antibody responses by cyclosporine. 
  • Interferon beta inhibits the Th17 cell-mediated autoimmune response in patients with relapsing-remitting multiple sclerosis. 
  • Interleukin 12 protects from a T helper type 1-mediated autoimmune disease, experimental autoimmune uveitis, through a mechanism involving interferon gamma, nitric oxide, and apoptosis. 
  • Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. 
  • Intraepidermal neutrophilic IgA dermatosis in an HIV-infected patient. 
  • Intravital imaging of Ca(2+) signals in lymphocytes of Ca(2+) biosensor transgenic mice: indication of autoimmune diseases before the pathological onset. 
  • Involvement of urokinase-type plasminogen activator in acantholysis induced by pemphigus IgG. 
  • Lack of correlation between serum soluble Fas/APO-1 levels and autoimmune disease. 
  • Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis. 
  • Lambert-Eaton myasthenic syndrome: clinical diagnosis, immune-mediated mechanisms, and update on therapies. 
  • Laser Light Therapy in Inflammatory, Musculoskeletal, and Autoimmune Disease. 
  • Liposarcoma presenting as an intraluminal ureteral mass. 
  • Longterm followup and quality of life after hematopoietic stem cell transplantation. 
  • Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. 
  • Maintenance of long-lived plasma cells and serological memory despite mature and memory B cell depletion during CD20 immunotherapy in mice. 
  • Management of Gardner-Diamond syndrome with therapeutic plasma exchange. 
  • Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment. 
  • Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors. 
  • Mechanisms of polyclonal B-cell activation in autoimmune B6-lpr/lpr mice. 
  • Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases. 
  • Mice deficient in inducible nitric oxide synthase are susceptible to experimental autoimmune uveoretinitis. 
  • Microchimerism in children with rheumatic disorders: what does it mean? 
  • Microparticles as biomarkers in autoimmunity: from dust bin to center stage. 
  • Modulating the wayward T cell: New horizons with immune checkpoint inhibitor treatments in autoimmunity, transplant, and cancer. 
  • Molecular structure of the La and Ro autoantigens and their use in autoimmune diagnostics. 
  • Monoclonal rheumatoid factors from B6-lpr/lpr mice. 
  • Moonlighting chromatin: when DNA escapes nuclear control. 
  • Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. 
  • Multimodal imaging in non-paraneoplastic autoimmune retinopathy. 
  • Multiple, thin-walled cystic lesions of the lung. 
  • Multiplexed protein array platforms for analysis of autoimmune diseases. 
  • Muscle autoantibodies in myasthenia gravis: beyond diagnosis? 
  • Mycophenolate mofetil in the treatment of pediatric autoimmune central nervous system disease. 
  • Myeloid Cells in the Central Nervous System. 
  • Negative control of diacylglycerol kinase ζ-mediated inhibition of T cell receptor signaling by nuclear sequestration in mice. 
  • Negative regulation of T cell activation and autoimmunity by the transmembrane adaptor protein LAB. 
  • Neonatal alloimmune thrombocytopenic purpura. 
  • Neonatal alloimmune thrombocytopenic purpura: a case report. 
  • Neonatal experimental autoimmune myasthenia gravis. 
  • Neuromuscular Disorders and Pregnancy. 
  • Neuromuscular blocking properties of suxamethonium and decamethonium in normal and myasthenic rat muscle. 
  • Neutrophil accumulation and NET release contribute to thrombosis in HIT. 
  • New insights into angiotensin receptor actions: from blood pressure to aging. 
  • New prospects for autoimmune disease therapy: B cells on deathwatch. 
  • New reagents on the horizon for immune tolerance. 
  • New surrogate markers for autoimmune disease activity. 
  • Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice. 
  • Nitrosylation of blood hemoglobin and renal nonheme proteins in autoimmune MRL-lpr/lpr mice. 
  • Novel targeted therapies for autoimmunity. 
  • One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up. 
  • PILAR is a novel modulator of human T-cell expansion. 
  • Pancreatic ductal adenocarcinoma with autoimmune pancreatitis-like histologic and immunohistochemical features. 
  • Pathways of apoptosis in lymphocyte development, homeostasis, and disease. 
  • Peroxynitrite formation and decreased catalase activity in autoimmune MRL-lpr/lpr mice. 
  • Persistent antibody depletion after rituximab in three children with autoimmune cytopenias. 
  • Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease. 
  • Phenotype standardization for statin-induced myotoxicity. 
  • Pitfalls in avoiding operation for autoimmune pancreatitis. 
  • Pre-existing autoimmune disease in patients with long-term survival after allogeneic bone marrow transplantation. 
  • Prediction of outcome in fetal autoimmune complete heart block. 
  • Proceedings from the American College of Rheumatology Reproductive Health Summit: the management of fertility, pregnancy, and lactation in women with autoimmune and systemic inflammatory diseases. 
  • Profiling and targeting connective tissue remodeling in autoimmunity - A novel paradigm for diagnosing and treating chronic diseases. 
  • Proliferative glomerulonephritis in children. A correlation of varied clinical and pathologic patterns utilizing light, immunofluorescence, and electron microscopy. 
  • Pseudotumors due to IgG4 immune-complex tubulointerstitial nephritis associated with autoimmune pancreatocentric disease. 
  • Qa-1 restriction of CD8+ suppressor T cells. 
  • RECONSTITUTION OF THE ELLIPSOID ZONE WITH TOCILIZUMAB IN AUTOIMMUNE RETINOPATHY. 
  • Rasmussen's encephalitis: an autoimmune disorder? 
  • Rasmussen's encephalitis: an autoimmune disorder? 
  • Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases. 
  • Reconstitution of the human biome as the most reasonable solution for epidemics of allergic and autoimmune diseases. 
  • Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). 
  • Regulation of T-helper-cell lineage development by osteopontin: the inside story. 
  • Regulatory B cells as inhibitors of immune responses and inflammation. 
  • Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation. 
  • Relevance of systemic lupus erythematosus nephritis animal models to human disease. 
  • Retinitis pigmentosa: clinical management based on current concepts. 
  • Risk of Adverse Outcomes in Hospitalized Patients With Autoimmune Disease and COVID-19: A Matched Cohort Study From New York City. 
  • Risk of venous thromboembolism among hospitalizations of adults with selected autoimmune diseases. 
  • Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees. 
  • Role of immune stimulation in the etiology of multiple myeloma: a case control study. 
  • Role of interleukin 12 and costimulators in T cell anergy in vivo. 
  • SARILUMAB FOR RECALCITRANT CYSTOID MACULAR EDEMA IN NON-PARANEOPLASTIC AUTOIMMUNE RETINOPATHY. 
  • Safety and efficacy of immune checkpoint inhibitors in advanced urological cancers with pre-existing autoimmune disorders: a retrospective international multicenter study. 
  • Screening pregnant women for autoimmune thyroid disease: a cost-effectiveness analysis. 
  • Self and non-self discrimination of intracellular membranes by the innate immune system. 
  • Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis. 
  • Similar CD19 dysregulation in two autoantibody-associated autoimmune diseases suggests a shared mechanism of B-cell tolerance loss. 
  • Sjögren's syndrome and autoimmunity. 
  • Skewed VH and V kappa gene family expression and pairing occurs among B lymphocytes in autoimmune motheaten mice. 
  • Skewing of the population balance of lymphoid and myeloid cells by secreted and intracellular osteopontin. 
  • Specificity and idiotypic analysis of a monoclonal anti-Sm antibody with anti-DNA activity. 
  • Spectrum of immune-mediated inner ear disease and cochlear implant results. 
  • Stem Cell Therapy as a Treatment for Autoimmune Disease-Updates in Lupus, Scleroderma, and Multiple Sclerosis. 
  • Strategies to circumvent humoral immunity to adeno-associated viral vectors. 
  • Susac syndrome with transient inverted vision. 
  • Systematic Review of Treatments for Autoimmune Inner Ear Disease. 
  • Systemic autoimmune nephritogenic components induce CSF-1 and TNF-alpha in MRL kidneys. 
  • T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. 
  • TCR repertoire and CDR3 motif analyses depict the role of αβ T cells in Ankylosing spondylitis. 
  • TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease. 
  • Takinib, a Selective TAK1 Inhibitor, Broadens the Therapeutic Efficacy of TNF-α Inhibition for Cancer and Autoimmune Disease. 
  • Tgf-beta inhibits activation and uveitogenicity of primary but not of fully polarized retinal antigen-specific memory-effector T cells. 
  • The CD19-CD21 signal transduction complex of B lymphocytes regulates the balance between health and autoimmune disease: systemic sclerosis as a model system. 
  • The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases. 
  • The Interaction of Anti-DNA Antibodies with DNA: Evidence for Unconventional Binding Mechanisms. 
  • The Regulatory B Cell Compartment Expands Transiently During Childhood and Is Contracted in Children With Autoimmunity. 
  • The Role of Pediatric Rheumatologists in Autoimmune Brain Disease. 
  • The Role of the Adipokine Leptin in Immune Cell Function in Health and Disease. 
  • The antigenic properties of bacterial DNA in normal and aberrant immunity. 
  • The association between immunodeficiency and the development of autoimmune disease. 
  • The clearance of a monoclonal anti-DNA antibody following administration of DNA in normal and autoimmune mice. 
  • The clinical utility of immunoglobulin G4 in the evaluation of autoimmune pancreatitis and pancreatic adenocarcinoma. 
  • The dual role of IL-10. 
  • The evolving role of blood and marrow transplantation for the treatment of autoimmune diseases. 
  • The eye: A window to the soul of the immune system. 
  • The immunologic properties of DNA. 
  • The importance of the Erk pathway in the development of linker for activation of T cells-mediated autoimmunity. 
  • The influence of the lpr gene on B cell activation: differential antibody expression in lpr congenic mouse strains. 
  • The multifaceted role of Fas signaling in immune cell homeostasis and autoimmunity. 
  • The nephritogenic immune response. 
  • The new approach to assignment of ASFA categories--introduction to the fourth special issue: clinical applications of therapeutic apheresis. 
  • The pathologic and clinical intersection of atopic and autoimmune disease. 
  • The role of HMGB1 in the pathogenesis of inflammatory and autoimmune diseases. 
  • The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity. 
  • The role of cell death in the pathogenesis of autoimmune disease: HMGB1 and microparticles as intercellular mediators of inflammation. 
  • The role of cystoid macular edema as a marker in the progression of non-paraneoplastic autoimmune retinopathy. 
  • The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. 
  • Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. 
  • Thrombosis, thrombophilia, and thromboprophylaxis in pregnancy. 
  • Thymic epithelial defects and predisposition to autoimmune disease in BB rats. 
  • Thymoma followed by paroxysmal nocturnal hemoglobinuria: a unique clinical association in the context of multiorgan autoimmunity with a potential role for CD8+ T lymphocytes. 
  • Thymus transplantation for complete DiGeorge syndrome: European experience. 
  • Toll-like receptors in the pathogenesis of human disease. 
  • Total lymphoid irradiation as an immunosuppressive agent for transplantation and the treatment of 'autoimmune' disease: a review. 
  • Transgenic expression of the viral FLIP MC159 causes lpr/gld-like lymphoproliferation and autoimmunity. 
  • Transgenic tubular cell expression of class II is insufficient to initiate immune renal injury. 
  • Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research. 
  • Treatment of autoimmune disease with extracorporeal photochemotherapy: pemphigus vulgaris--preliminary report. 
  • Treatment of platelet alloimmunization with intravenous immunoglobulin. Two case reports and review of the literature. 
  • Tristetraprolin as a Therapeutic Target in Inflammatory Disease. 
  • Unusual clinical and immunologic manifestations of transplacentally acquired maternal T cells in severe combined immunodeficiency. 
  • Updates on diagnosis and management of autoimmune blistering diseases. 
  • Updates on the management of autoimmune blistering diseases. 
  • Use of Autologous Serum Tears for the Treatment of Ocular Surface Disease From Patients With Systemic Autoimmune Diseases. 
  • Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. 
  • Uveitis and arthritis: experimental models and clinical correlates. 
  • Uveitis in children. 
  • [IL-21 induces regulatory B cell differentiation and immunosuppressive effect through cognate interaction with T cells]. 
  • [IgA pemphigus. Successful treatment with mycophenolate mofetil]. 
• 

  Keywords of People

  • Arepally, Gowthami Morey, Professor of Medicine, Pathology
  • Bilbo, Staci D., Haley Family Professor of Psycology and Neuroscience, Psychology & Neuroscience
  • Bradford, William Dalton, Professor of Pathology, Pathology
  • Chen, Jun, Professor of Medicine, Duke Cancer Institute
  • Ciofani, Maria, Associate Professor of Integrative Immunobiology, Cell Biology
  • Kelsoe, Garnett H., James B. Duke Distinguished Professor of Immunology, Integrative Immunobiology
  • Lee, Kate, House Staff, Medicine
  • Mruthyunjaya, Prithvi, Adjunct Associate Professor in the Department of Ophthalmology, Ophthalmology, Vitreoretinal Diseases & Surgery
  • Shinohara, Mari L., Professor of Integrative Immunobiology, Cell Biology
  • Wray, Gregory Allan, Professor of Biology, Evolutionary Anthropology
  • Yi, John S, Adjunct Assistant Professor in the Department of Surgery, Surgery, Surgical Sciences